plozalizumabPRO-140COVID-19multi-organ failureacute respiratory distress syndromeItalian Ministry of Health
…ur hours post-infection, cells were treated with the antibodies plozalizumab (anti-CCR2) or PRO-140 (anti-CCR5). In selected experiments, fr…